Cardiomyopathy as the initial presentation of phaeochromocytoma (PCA) is uncommon.
Diagnostic work-up and perioperative management may be challenging within this context …

Objective To review the pathogenesis as well as the clinical and laboratory features of
catecholamine-induced cardiomyopathy associated with pheochromocytoma and other …

Background Clinical manifestations of pheochromocytoma (PCC) frequently are not specific
and can be attributed to other pathologies. The most dreaded manifestation is …

Acute catecholamine cardiomyopathy is an uncommon, life-threatening manifestation of
pheochromocytoma. The massive release of catecholamines from the adrenal medulla and …

A 27-year-old patient presented with a 3-month history of episodic headaches and
persistently rising blood pressure (up to 240/120). The clinical, laboratory, and instrumental …

Objective Phaeochromocytomas and paragangliomas (PPGL) can cause acute
catecholamine cardiomyopathy (ACC). We assessed the prevalence of ACC and compared …

Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies:... : Medicine Acute and
Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic …

A phaeochromocytoma (PC) is a rare, catecholamine-secreting neuroendocrine tumour
arising from the adrenal medulla. Presenting symptoms of this rare tumour are highly …

Objective: Different types of pheochromocytoma-related cardiomyopathies have been
described in literature, but predictive factors of their occurrence and evolution are not yet …

Objective To investigate possible predictive factors of catecholamine-induced
cardiomyopathy in pheochromocytoma and paraganglioma (CICMPP) patients. Methods In …